unknown
Stage
1
Investors
About
Cellply is a life sciences company that develops in vitro diagnostic platforms to support personalized cancer treatment by providing tools to guide therapy decisions. Their work focuses on diagnostics for oncology to enable more tailored patient care.
Explore Cellply's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.